Kosmix
One sec... we're building your guide for
Subgroup Analysis
Subgroup analysis
Overview
Main ›
Tweets
Twitter.com
One sec... we're getting the
Tweets
More from Twitter.com »
Related in the Kosmos
?
Medical statistics
(58)
Absolute risk reduction
Hazard ratio
Meta analysis
Number needed to treat
Odds ratio
Odds ratio
Post-hoc analysis
Relative risk
Relative risk reduction
Age-standardized mortality rate
Armitage–Doll multistage model of carcinogenesis
Attack rate
Barber–Johnson diagram
Berkson's paradox
Bland–Altman plot
Cancer cluster
Ceiling effect
Censoring (clinical trials)
Clinical research
Clinical significance
Clinical trial
Clinical utility of diagnostic tests
Cohort effect
Control event rate
Cuzick–Edwards test
Cytel
Drug test
Economic epidemiology
Effect size
End point of clinical trials
Epidemic model
Experimental event rate
First-in-man study
Health care analytics
Heart rate variability
Incidence (epidemiology)
Interim analysis
Lead time bias
Matching (statistics)
Mathematical modelling of infectious disease
Meadow's law
Mortality rate
Multiple of the median
Number needed to harm
Number needed to vaccinate
Open-label trial
Prevalence
Rare disease assumption
Relative survival
Risk factor
Risk-benefit analysis
Rule of three (medicine)
Sensitivity and specificity
Standardised mortality rate
Standardized mortality ratio
Study design
Surrogate endpoint
Therapeutic effect
Transmission risks and rates
more...
Medical research
Systematic review
Meta analysis
Medical journals
J Manipulative Physiol Ther
N Engl J Med
J. Clin. Oncol.
J Am Osteopath Assoc
Arch Intern Med
Systematic review
(15)
Cochrane review
Publication bias
Cochrane Library
Critical appraisal
Drug Effectiveness Review Project
Drug Effectiveness Review Project
EPPI-Centre
Forest plot
Funnel plot
Galbraith plot
Meta analysis
Natural Standard
QUOROM flow chart
Secondary data
Study heterogeneity
Thomas C. Chalmers
more...
Evidence-based medicine
(32)
Randomized controlled trials
Archie Cochrane
Bestbets
Child Health Field
Clinical prediction rule
Clinical prediction rule
Cochrane review
Critical appraisal
Disease registry
Donald Berwick
EPPI-Centre
Evidence-based nursing
Evidence-based pharmacy in developing countries
Fee splitting
Forest plot
German Network for Evidence Based Medicine
Gordon Guyatt
Guidelines International Network
Healthcare error proliferation model
Integrated Single Specialty Provider
Levels of evidence
Meta analysis
Natural Standard
New Century Infusion Solutions, Inc.
Number needed to harm
PIER
Patient safety
Personalized medicine
Peter Pronovost
Secondary research
Sifap
Systematic review
Thomas C. Chalmers
more...
Research methods
Placebo-controlled trial
Meta analysis
Systematic review
Publication bias
Aging-associated diseases
Chronic heart failure
Hypertensive
Acute myocardial infarction
Cardiovascular diseases
Essential hypertension
Intima media thickness
Chronic heart failure
Hypertensive
Acute myocardial infarction
Cardiology
(12)
Isolated systolic hypertension
Ambulatory blood pressure
The Scandinavian Simvastatin Survival Study
NYHA
Percutaneous coronary intervention
Percutaneous coronary intervention
Thrombolysis
Coronary stent
LDL-C
Chronic heart failure
Hypertensive
Essential hypertension
Intima media thickness
more...
Epidemiology
(10)
Case control studies
Intention to treat analysis
Hazard ratio
Randomized controlled trials
Absolute risk reduction
Absolute risk reduction
The Scandinavian Simvastatin Survival Study
Relative risk
Relative risk reduction
Odds ratio
Number needed to treat
more...
Hematology
Activated protein C
D dimer
Venous thromboembolism
Alteplase
Fondaparinux
Medical terms
Progression Free Survival
Secondary prevention
Prognostic
Monotherapy
Placebo
Intensive care medicine
Apache II
Severe sepsis
Xigris
Goal-directed therapy
See also
(20)
Subgroup
Systolic dysfunction
Allocation concealment
Normal subgroup
Fondaparinux
Fondaparinux
External validity
ISIS-2
Ivabradine
Placebo
Internal validity
Vinorelbine
Left ventricular
Antiplatelet
Nassim Nicholas Taleb
Statistically significant
Mm Hg
ST segment
Thrombolytic therapy
Multivariate statistics
Cytopathic
more...
more categories...
